A New Treatment Strategy for Synovial Sarcoma
Synovial sarcoma is a rare, aggressive soft tissue cancer with few effective treatment options. Duke researchers, including Pathology’s Dr. Ling Cai, have found a weakness in the disease, suggesting a possible new treatment.
Scientists Hack Cell Entry to Supercharge Cancer Drugs
Work by Duke University School of Medicine cancer researcher and pathology professor Dr. Hui-Kuan Lin could help revive drugs once considered too big to work.
Dr. Thomas J. Cummings Represented Duke Pathology at Three Meetings on Medical Education
Professor of Pathology and Ophthalmology and Residency Program Director Thomas J.
Patients in Pathology Event Sparks Students’ Interest in the Field
On March 26th, 2025, the Pathology Interest Group hosted its Patients in Pathology event to encourage exploration of the often-misunderstood practice of pathology.
Dr. Jadee Neff Invited to CAP Today Webinar to Discuss a Disease That’s Hard to Diagnose
Idiopathic multicentric Castleman disease is a difficult diagnosis and one that’s often delayed, owing to the disease’s rarity and nonspecific symptoms.